In all the above mentioned trials as well as in our study, there was no information on the amount of patients with low molecular weight apo(a) phenotype, which in combination with high Lp(a) concentrations has been shown to increase the risk of atherosclerosis, e.g. coronary heart disease and LEAD [38, 39]. This evidence concerns the gene LPA and atherosclerosis.